Feed IMPZY
IM

Implanet S.A.

IMPZY · OTC

$0.08 +0.00% (+$0.00)
Market Cap 204.4M €
P/E Ratio -
Div. Yield 0.22%
ROE 515.03%
Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
4/9
Valuation
0 /100
Expensive
P/S 17.06x
P/B 505.96x
P/E N/A
Growth
65 /100
Stable
Rev. growth 14.28%
Book val. growth 51.50%
EPS growth N/A
Profitability
20 /100
Weak
Gross margin 55.28%
FCF margin 17.94%
Net margin 35.13%
Quality
8 /100
Poor
ROIC 61.88%
Asset turnover 0.65x
ROE 515.03%
Debt
6 /100
High
Debt/Equity 14.66x
Int. coverage -30.33x
Current ratio 0.80x
Stability
58 /100
Moderate
Beta 0.63x
Profitable years 0
Rev. volatility 19.68%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about IMPZY
Online

Sector

Healthcare

Industry

Medical - Devices

CEO

Ludovic Lastennet

Employees

46

Headquarters

Martillac

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.